Alexion Pharmaceuticals, Inc.
Methods for treating hypophosphatasia in adolescents and adults

Abstract:

The disclosure features methods for treating hypophosphatasia (HPP) in a patient (e.g., adolescent or adult having HPP) exhibiting physical impairments or decreased walking ability by administering a soluble alkaline phosphatase (sALP) to the patient.